Skip to main content

SYNACT · SynAct Pharma AB · Debt

17.1200 SEK -0.6800 (-3.82%) At close · Oct 5
Market Cap
968.77M SEK
Shares
56.00M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2025-12-31 SEK 616,000 ESEF Annual Report filed 2026-04-15
Noncurrent lease liabilities 2025-12-31 SEK 595,000 ESEF Annual Report filed 2026-04-15
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.